 Source: Viacheslav Lopatin Shutterstock.com Applied DNA Sciences NASDAQ: APDN stock is rising higher on Friday after the company sent its monkeypox test to the NYSDOH for approval. According to a press release, Applied DNAs Linea Monkeypox Virus 1.0 Assay is designed to identify the genetic signature of the Clade II variant of the monkeypox virus that is currently prevalent in the U.S. Applied DNA is hoping for approval that designates its monkeypox test as an NYSDOH Laboratory Developed Test LDT. 